6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity-Reference-Cited by-同舟云学术

6-Substituted-4-(3-bromophenylamino)quinazolines as Putative Irreversible Inhibitors of the Epidermal Growth Factor Receptor (EGFR) and Human Epidermal Growth Factor Receptor (HER-2) Tyrosine Kinases with Enhanced Antitumor Activity

Published:2001-07-14 Issue:17 Volume:44 Page:2719-2734
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Tsou Hwei-Ru¹,Mamuya Nellie¹,Johnson Bernard D.¹,Reich Marvin F.¹,Gruber Brian C.¹,Ye Fei¹,Nilakantan Ramaswamy¹,Shen Ru¹,Discafani Carolyn¹,DeBlanc Ronald¹,Davis Rachel¹,Koehn Frank E.¹,Greenberger Lee M.¹,Wang Yu-Fen¹,Wissner Allan¹

Affiliation:

1. Wyeth-Ayerst Research, A Division of American Home Products, 401 N. Middletown Road, Pearl River, New York 10965-1215

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/jm0005555

Reference26 articles.

1. Expression of epidermal growth factor receptor and proliferating cell nuclear antigen predicts response of esophageal squamous cell carcinoma to chemoradiotherapy

2. Small molecule inhibitors of receptor tyrosine kinases

Cited by 257 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-Probe Activity-Based Protein Profiling Reveals Site-Specific Differences in Protein Binding of EGFR-Directed Drugs;2023-10-19

2. Development and Applications of Chimera Platforms for Tyrosine Phosphorylation;ACS Central Science;2023-08-09

3. Quantum Descriptors for Predicting and Understanding the Structure–Activity Relationships of Michael Acceptor Warheads;Journal of Chemical Information and Modeling;2023-07-18

4. Discovery and Structural Optimization of Novel Quinolone Derivatives as Potent Irreversible Pan-Fibroblast Growth Factor Receptor Inhibitors for Treating Solid Tumors;Journal of Medicinal Chemistry;2023-06-19

5. Role and mechanistic actions of protein kinase inhibitors as an effective drug target for cancer and COVID;Archives of Microbiology;2023-05-17